Legend Biotech Files 6-K, Confirms 20-F Reporting
Ticker: LEGN · Form: 6-K · Filed: Jul 2, 2024 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jul 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulatory, foreign-private-issuer
TL;DR
Legend Biotech filed a 6-K, confirming they'll use Form 20-F for annual reports. No new financials.
AI Summary
Legend Biotech Corp. filed a Form 6-K on July 2, 2024, reporting as a foreign private issuer. The filing indicates the company will file its annual reports under Form 20-F. No other specific financial or operational details were provided in this particular filing.
Why It Matters
This filing confirms Legend Biotech's reporting status with the SEC, which is standard for foreign private issuers and provides transparency for investors regarding their regulatory filings.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting procedures, not containing new material financial or operational information.
Key Players & Entities
- Legend Biotech Corp. (company) — Filer of the Form 6-K
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form for foreign private issuers
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating the company's reporting status.
Which form will Legend Biotech use for its annual reports?
Legend Biotech indicates it will file its annual reports under cover of Form 20-F.
What is the filing date of this report?
The filing date of this report is July 2, 2024.
What is the Commission File Number for Legend Biotech?
The Commission File Number for Legend Biotech is 001-39307.
Does this filing contain specific financial results or operational updates?
Based on the provided text, this filing appears to be a routine administrative report and does not contain specific financial results or operational updates.
Filing Stats: 329 words · 1 min read · ~1 pages · Grade level 16.2 · Accepted 2024-07-02 08:00:07
Filing Documents
- f6k_070224.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 38KB
- 0001171843-24-003760.txt ( ) — 46KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: July 2, 2024 /s/ Ying Huang Ying Huang Chief Executive Officer